APA

Krupashankar D. S., Dogra S., Kura M., Saraswat A., Budamakuntla L., Sumathy T. K., Shah R., Gopal M. G., Narayana Rao T., Srinivas C. R., Bhat R., Shetty N., Manmohan G., Sai Krishna K., Padmaja D., Pratap D. V. S., Garg V., Gupta S., Pandey N., Khopkar U., Montero E., Ramakrishnan M. S., Nair P. & Ganapathi P. C. (20150122). Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study. : Journal of the American Academy of Dermatology.

Chicago

Krupashankar D S, Dogra Sunil, Kura Mahendra, Saraswat Abir, Budamakuntla Leelavathy, Sumathy T K, Shah Radha, Gopal M G, Narayana Rao T, Srinivas C R, Bhat Ramesh, Shetty Narendra, Manmohan G, Sai Krishna Kotla, Padmaja Dalavoi, Pratap Dasiga Venkata Subrahmanya, Garg Vijay, Gupta Sandesh, Pandey Neeraj, Khopkar Uday, Montero Enrique, Ramakrishnan M S, Nair Pradip and Ganapathi Prasanna C. 20150122. Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study. : Journal of the American Academy of Dermatology.

Harvard

Krupashankar D. S., Dogra S., Kura M., Saraswat A., Budamakuntla L., Sumathy T. K., Shah R., Gopal M. G., Narayana Rao T., Srinivas C. R., Bhat R., Shetty N., Manmohan G., Sai Krishna K., Padmaja D., Pratap D. V. S., Garg V., Gupta S., Pandey N., Khopkar U., Montero E., Ramakrishnan M. S., Nair P. and Ganapathi P. C. (20150122). Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study. : Journal of the American Academy of Dermatology.

MLA

Krupashankar D S, Dogra Sunil, Kura Mahendra, Saraswat Abir, Budamakuntla Leelavathy, Sumathy T K, Shah Radha, Gopal M G, Narayana Rao T, Srinivas C R, Bhat Ramesh, Shetty Narendra, Manmohan G, Sai Krishna Kotla, Padmaja Dalavoi, Pratap Dasiga Venkata Subrahmanya, Garg Vijay, Gupta Sandesh, Pandey Neeraj, Khopkar Uday, Montero Enrique, Ramakrishnan M S, Nair Pradip and Ganapathi Prasanna C. Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study. : Journal of the American Academy of Dermatology. 20150122.